BIOPORTO A/S - SUBMITS FDA PRE-SUBMISSION PACKAGE FOR U.S. ADULT URINE NGAL PROGRAM
BIOPORTO A/S - ANNOUNCEMENT DOES NOT ALTER BIOPORTO'S FINANCIAL GUIDANCE AS RECENTLY PUBLISHED ON 5 FEBRUARY 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.